When managing major depressive disorder (MDD), assessing response to treatment can be a complex undertaking. Structured clinician- and patient-rated scales have been developed to assist with this task. Test your knowledge on the clinical tools and considerations that can aid your evaluation of treatment response in MDD.
References
American Psychiatric Association. Practice Guideline for the Treatment of Patients With Major Depressive Disorder. 3rd ed. American Psychiatric Association; 2010.
Yavorsky C, Ballard E, Opler M, Sedway J, Targum SD, Lenderking W. Recommendations for selection and adaptation of rating scales for clinical studies of rapid-acting antidepressants. Front Psychiatry. 2023;14:1135828. doi:10.3389/fpsyt.2023.1135828
Spitzer RL, Kroenke, K, Williams, JB. Validation and utility of a self-report version of PRIME-MD: The PHQ Primary Care study. JAMA. 1999;282(18):1737-1744. doi:10.1001/jama.282.18.1737
McIntyre R, Kennedy S, Bagby RM, Bakish D. Assessing full remission. J Psychiatry Neurosci. 2002;27(4):235-239.
Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56–62. doi:10.1136/jnnp.23.1.56
Bagby RM, Ryder AG, Schuller DR, Marshall MB. The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry. 2004;161(12):2163-2177. doi:10.1176/appi.ajp.161.12.2163
Ma S, Yang J, Yang B, et al. The Patient Health Questionnaire-9 vs. the Hamilton Rating Scale for Depression in assessing major depressive disorder. Front Psychiatry. 2021;12:747139. doi:10.3389/fpsyt.2021.747139
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613. doi:10.1046/j.1525-1497.2001.016009606.x
Desseilles M, Witte J, Chang TE, et al. Assessing the adequacy of past antidepressant trials: a clinician’s guide to the Antidepressant Treatment Response Questionnaire (ATRQ). J Clin Psychiatry. 2011;72(8):1152-1154. doi:10.4088/JCP.11ac07225
Chandler GM, Iosifescu DV, Pollack MH, Targum SD, Fava M. RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ). CNS Neurosci Ther. 2010;16(5):322-325. doi:10.1111/j.1755-5949.2009.00102
Löwe B, Unützer J, Callahan CM, Perkins AJ, Kroenke K. Monitoring depression treatment outcomes with the patient health questionnaire-9. Med Care. 2004; 42(12):1194-201. doi:10.1097/00005650-200412000-00006
Morrens J, Mathews M, Popova V, et al. Use of Clinical Global Impressions-Severity (CGI-S) to assess response to antidepressant treatment in patients with treatment-resistant depression. Neuropsychiatr Dis Treat. 2022;18:1127-1132. doi:10.2147/NDT.S358367
McClintock SM, Husain MM, Wisniewski ST, et al. Residual symptoms in depressed outpatients who respond by 50% but do not remit to antidepressant medication. J Clin Psychopharmacol. 2011;31(2):180-186. doi:10.1097/JCP.0b013e31820ebd2c
This resource is intended for educational purposes only and is intended for US health care professionals. Health care professionals should use independent medical judgment. All decisions regarding patient care must be handled by a health care professional and be made based on the unique needs of each patient.
ABBV-US-01347-MC, Version 1.0 Approved 10/2023 AbbVie Medical Affairs
Links to sites outside of NP Psych Navigator are provided as a resource to the viewer. AbbVie Inc accepts no responsibility for the content of non-AbbVie linked sites.
